Board Member at Five Prime Therapeutics, Inc.
Mr. Berger started his consulting practice, FMB Research, in 2003 after leaving J. P. Morgan Securities, Inc. as head of biotechnology equity research. His clients were exclusively biotechnology industry participants including major biopharmaceutical firms, mid-capitalization biotechnology companies, specialist asset managers and venture capital companies. Assignments included business development, strategic advisory/financings, partnering and royalty acquisitions. Past mandates included PDL BioPharma, Inc., Intra-Cellular Therapeutics, Inc., Serono, Merck KGaA, Threshold Pharmaceuticals, Valeant, Kleiner Perkins Caufield & Byers (incomplete ...
Source: Kezar Life Sciences, Inc. on 03/31/2017
By accessing BoardEdge, you can view bios, network, connections and references of industry leading executives like Franklin M. Berger. More specifically, you'll be able to:
Access over 170,000 executive and board member profiles.
Example: Franklin M. Berger
Interested in updating your biography and work history?
We're working on making it happen.
We'll email you when this feature is available.
Please enter valid email address.
Thank you for your interest.